Market
Highlights
High-intensity focused ultrasound (HIFU) therapy is a novel,
emerging, and therapeutic modality technology. It involves propagation of
ultrasound waves through cancerous tissues that kills cancer cells. HIFU is a
minimal invasive technique and is performed with real-time imaging by
ultrasound or MRI to enable treatment targeting and monitoring. This technology
have been extensively exploited for the treatment of prostate, liver,
pancreatic, and bladder cancer. The American Cancer Society estimated that about
161,360 new cases of prostate cancer have been registered in the US in 2017.
Moreover, the number of people living beyond a cancer diagnosis were nearly
14.5 million in 2014 and is expected to rise to over 19 million by 2024.
Moreover, increasing development in the medical technology and its wide range
of application used in the treatment of uterine fibroids, neurological
disorders, cosmetic medicine and others fuel the growth of this market.
However, high cost of the treatment and certain adverse effects are likely to
restrain the market growth over the forecasted period.
The
global HIFU treatment
market is expected to grow at a CAGR of 7.8% during the forecast
period 2017-2023.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/885
Major Players in High intensity focused ultrasound (HIFU) therapy
Market
Some of the key players in the global market are Image Guided
Therapy, EDAP TMS, SonaCare Medical, LLC, Theraclion, Chongqing Haifu Medical
Technology Co., Ltd, Koninklijke Philips N.V., Shanghai A&S Co. LTD,
Mianyang Sonic Electronic Ltd., Insightec, Alpinion Medical Systems, and FUS
Instruments.
Regional Analysis
The
global high intensity focused ultrasound (HIFU) therapy market
consists of four regions including the Americas, Europe, Asia Pacific, and the
Middle East & Africa.
The
Americas dominates the global HIFU therapy market. North America is
the largest market owing to rising prevalence of cancer cases in the American
counties and well-developed technology in this region contributes majorly to
the growth of this market.
Europe
accounts for the second largest share of the global HIFU therapy market. In the
Europe, wide demand for cancer diseases treatment methods drives the market
growth. Moreover, increasing expenditure in the healthcare domain and
investment in research & development in developing new treatment methods
for cancer diseases will fuel to the growth of this market.
Asia
Pacific is the fastest growing market in the world. India is the largest
potential market due to increasing investments in healthcare services and
increasing adaption of new technologies used for diagnosis and treatment
methods.
The
Middle East & Africa is expected to witness a steady growth due to rising
demand for primary healthcare services such as new and advanced treatment
methods in healthcare domain.
Segmentation
The
global high intensity focused ultrasound (HIFU) therapy market has been
segmented on the basis of modality, which comprises of therapeutic ultrasound,
hemostasis, lithotripsy, thrombolysis, immunomodulation, and others. On the
basis of the methods, the market is segmented into non-invasive method and
minimal invasive method. On the basis of applications, the market has been
segmented into prostate cancer, uterine fibroids, neurological disorders,
cosmetic medicine, and others. On the basis of end users, the market has been
segmented into diagnostic centers, hospitals, research centers, and others.
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/high-intensity-focused-ultrasound-therapy-market-885
No comments:
Post a Comment